Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 4, 2009, Pages

  Honda, Tetsuya ^a   Matsuoka, Toshiyuki ^a   Ueta, Mayumi ^b   Kabashima, Kenji ^a   Miyachi, Yoshiki ^a   Narumiya, Shuh ^a  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

contact hypersensitivity; EP3 receptor; Prostaglandin E2

Indexed keywords

AE 248; ANTIINFLAMMATORY AGENT; BETA GALACTOSIDASE; CHEMOKINE; CXCL1 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; HAPTEN; IMMUNOMODULATING AGENT; ONBO AE1 329; ONO AE1 259; ONO AE1 329; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP1 RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR ANTIBODY; PROSTAGLANDIN EP4 RECEPTOR; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1 FLUORO 2,4 DINITROBENZENE; CXCL1 PROTEIN, MOUSE; DRUG DERIVATIVE; EP3 PROTEIN, MOUSE; ONO AE 248;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; COMPARATIVE STUDY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; EAR; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; HISTOLOGY; KERATINOCYTE; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; SKIN; SKIN ALLERGY; STAINING; THICKNESS; WILD TYPE; ANIMAL; C57BL MOUSE; CONTACT DERMATITIS; DISEASE MODEL; DNA MICROARRAY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINE CXCL1; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449704188     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.04.029     Document Type: Article

References (34)

1. Grabbe S., and Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19 (1998) 37-44
2. Engeman T., Gorbachev A.V., Kish D.D., and Fairchild R.L. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 76 (2004) 941-949
3. Dilulio N.A., Engeman T., Armstrong D., Tannenbaum C., Hamilton T.A., and Fairchild R.L. Groalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur J Immunol 29 (1999) 3485-3495
4. Homey B., Alenius H., Muller A., Soto H., Bowman E.P., Yuan W., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8 (2002) 157-165
5. Mitsui G., Mitsui K., Hirano T., Ohara O., Kato M., and Niwano Y. Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. Immunol Lett 86 (2003) 191-197
6. Ruzicka T., and Printz M.P. Arachidonic acid metabolism in skin: experimental contact dermatitis in guinea pigs. Int Arch Allergy Appl Immunol 69 (1982) 347-352
7. Eberhard J., Jepsen S., Albers H.K., and Acil Y. Quantitation of arachidonic acid metabolites in small tissue biopsies by reversed-phase high-performance liquid chromatography. Anal Biochem 280 (2000) 258-263
8. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
9. Takeshita K., Yamasaki T., Nagao K., Sugimoto H., Shichijo M., Gantner F., et al. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 16 (2004) 947-959
10. Konger R.L., Brouxhon S., Partillo S., VanBuskirk J., and Pentland A.P. The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. Exp Dermatol 14 (2005) 914-922
11. Tober K.L., Thomas-Ahner J.M., Kusewitt D.F., and Oberyszyn T.M. Effects of UVB on E prostanoid receptor expression in murine skin. J Invest Dermatol 127 (2007) 214-221
12. Kunikata T., Yamane H., Segi E., Matsuoka T., Sugimoto Y., Tanaka S., et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 6 (2005) 524-531
13. Ahluwalia A., and Perretti M. Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors. J Pharmacol Exp Ther 268 (1994) 1526-1531
14. Goulet J.L., Pace A.J., Key M.L., Byrum R.S., Nguyen M., Tilley S.L., et al. E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 173 (2004) 1321-1326
15. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
16. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., and Narumiya S. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9 (2003) 744-749
17. Ueta M., Matsuoka T., Narumiya S., Kinoshita S., Tomimatsu H., Miyauchi Y., et al. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 123 (2009) 466-471
18. Honda T., Segi-Nishida E., Miyachi Y., and Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203 (2006) 325-335
19. Latta M., Mohan K., and Issekutz T.B. CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis. Immunology 121 (2007) 555-564
20. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202 (2005) 541-549
21. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11 (2005) 43-49
22. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437 (2005) 369-375
23. Tuckermann J.P., Kleiman A., Moriggl R., Spanbroek R., Neumann A., Illing A., et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117 (2007) 1381-1390
24. Nguyen M., Solle M., Audoly L.P., Tilley S.L., Stock J.L., McNeish J.D., et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 169 (2002) 4586-4593
25. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., and Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8 (2007) 1095-1104
26. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192 (2000) 1441-1452
27. Matsuoka T., and Narumiya S. Prostaglandin receptor signaling in disease. Sci World J 7 (2007) 1329-1347
28. Karsak M., Gaffal E., Date R., Wang-Eckhardt L., Rehnelt J., Petrosino S., et al. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316 (2007) 1494-1497
29. Kanda N., Mitsui H., and Watanabe S. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 114 (2004) 1403-1409
30. Scortegagna M., Cataisson C., Martin R.J., Hicklin D.J., Schreiber R.D., Yuspa S.H., et al. HIF-1{alpha} regulates epithelial inflammation by cell autonomous NF{kappa}B activation and paracrine stromal remodeling. Blood 111 (2008) 3343-3354
31. Hebborn P., Jablonska S., Beutner E.H., Langner A., and Wolska H. Action of topically applied arachidonic acid on the skin of patients with psoriasis. Arch Dermatol 124 (1988) 387-391
32. Ruzicka T., and Burg G. Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol 88 (1987) 120-123
33. Lazarova A.Z., Tsankov N.K., and Zlatkov N.B. Psoriasis induced by topically applied indomethacin. Clin Exp Dermatol 14 (1989) 260-261
34. Powles A.V., Griffiths C.E., Seifert M.H., and Fry L. Exacerbation of psoriasis by indomethacin. Br J Dermatol 117 (1987) 799-800